Entries Tagged as ''

NHS Diabetes Publishes Self-Monitoring Of Blood Glucose Report – Diabetes UK

A new report examines and makes recommendations about the issue of self-monitoring of blood glucose (SMBG) in people with Type 2 diabetes who are not treated with insulin. The report was commissioned by the National Clinical Director for Diabetes in England. An NHS Diabetes working group was established with relevant stakeholders to undertake it, and they have now published their report...

New Building At University Of Michigan Health System Expands Eye Care, Unites Diabetes Researchers

On March 1, the first eye patients will enter an innovative new $132 million facility that expands the University of Michigan Health System's capacity for eye care, research and education, and unites diabetes researchers as they work to accelerate the search for a cure and prevention of diabetes. The Brehm Tower at the W.K...

Exenatide Once Weekly New Drug Application Review Extended By FDA Due To Weather-Related Closure

Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) confirmed that the U.S. Food and Drug Administration (FDA) has set a new Prescription Drug User Fee Act (PDUFA) action date of March 12 for its review of the exenatide once weekly new drug application (NDA)...

Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans

Kimber L Stanhope, Jean Marc Schwarz, Nancy L Keim, Steven C Griffen, et al. Journal of Clinical Investigation. Ann Arbor: May 2009. Vol. 119, Iss. 5; p. 1322 (13 pages)
Available Formats:

[/images/common/ab.gif], Text+Graphics, Full Text - PDF

View more documents

More documents may be available. Follow the link to view all documents in ProQuest for your search.

Trends of Earlier and Later Responses of C-peptide to Oral Glucose Challenges With Progression to Type 1 Diabetes in Diabetes Prevention Trial-Type 1 Participants

Lack of Lipotoxicity Effect on {beta}-Cell Dysfunction in Ketosis-Prone Type 2 Diabetes

Islet Cell Antibody-Positive Versus -Negative Phenotypic Type 2 Diabetes in Youth: Does the oral glucose tolerance test distinguish between the two?

Hypoglycemia Aggravates Critical Illness-Induced Neurocognitive Dysfunction

Subjects With Early-Onset Type 2 Diabetes Show Defective Activation of the Skeletal Muscle PGC-1{alpha}/Mitofusin-2 Regulatory Pathway in Response to Physical Activity